267 related articles for article (PubMed ID: 25529146)
1. Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells.
Luo C; Yuan D; Yao W; Cai J; Zhou S; Zhang Y; Hei Z
Life Sci; 2015 Feb; 122():72-7. PubMed ID: 25529146
[TBL] [Abstract][Full Text] [Related]
2. The alpha2-adrenoreceptor agonist dexmedetomidine protects against lipopolysaccharide-induced apoptosis via inhibition of gap junctions in lung fibroblasts.
Zhang Y; Tan X; Xue L
Biochem Biophys Res Commun; 2018 Jan; 495(1):92-97. PubMed ID: 29101030
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects hippocampal neurons against hypoxia/reoxygenation-induced apoptosis through activation HIF-1α/p53 signaling.
Gao Y; Yin H; Zhang Y; Dong Y; Yang F; Wu X; Liu H
Life Sci; 2019 Sep; 232():116611. PubMed ID: 31260683
[TBL] [Abstract][Full Text] [Related]
4. Connexin32 gap junction channels deliver miR155-3p to mediate pyroptosis in renal ischemia-reperfusion injury.
Chen L; Fang H; Li X; Yu P; Guan Y; Xiao C; Deng Z; Hei Z; Chen C; Luo C
Cell Commun Signal; 2024 Feb; 22(1):121. PubMed ID: 38347637
[TBL] [Abstract][Full Text] [Related]
5. Propofol depresses the cytotoxicity of X-ray irradiation through inhibition of gap junctions.
Zhao Y; Liu B; Wang Q; Yuan D; Yang Y; Hong X; Wang X; Tao L
Anesth Analg; 2011 May; 112(5):1088-95. PubMed ID: 21415436
[TBL] [Abstract][Full Text] [Related]
6. Propofol attenuated acute kidney injury after orthotopic liver transplantation via inhibiting gap junction composed of connexin 32.
Luo C; Yuan D; Li X; Yao W; Luo G; Chi X; Li H; Irwin MG; Xia Z; Hei Z
Anesthesiology; 2015 Jan; 122(1):72-86. PubMed ID: 25254904
[TBL] [Abstract][Full Text] [Related]
7. Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression.
Wang Y; Li R; Qiao X; Tian J; Su X; Wu R; Zhang R; Zhou X; Li J; Shao S
Nephrology (Carlton); 2013 Sep; 18(9):623-32. PubMed ID: 23782291
[TBL] [Abstract][Full Text] [Related]
8. Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication.
Zhang YW; Morita I; Zhang L; Shao G; Yao XS; Murota S
Planta Med; 2000 Mar; 66(2):119-23. PubMed ID: 10763583
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
[TBL] [Abstract][Full Text] [Related]
10. Disruption of gap junctions attenuates aminoglycoside-elicited renal tubular cell injury.
Yao J; Huang T; Fang X; Chi Y; Zhu Y; Wan Y; Matsue H; Kitamura M
Br J Pharmacol; 2010 Aug; 160(8):2055-68. PubMed ID: 20649601
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
Wang K; Zhu Y
J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
[TBL] [Abstract][Full Text] [Related]
13. Involvement of tyrosine kinase in the hypoxia/reoxygenation-induced gap junctional intercellular communication abnormality in cultured human umbilical vein endothelial cells.
Zhang YW; Morita I; Nishida M; Murota SI
J Cell Physiol; 1999 Sep; 180(3):305-13. PubMed ID: 10430170
[TBL] [Abstract][Full Text] [Related]
14. Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain.
Li Z; Lin XM; Gong PL; Zeng FD; Du GH
Am J Chin Med; 2005; 33(6):923-34. PubMed ID: 16355449
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.
Zhou Z; Chen Q; Wan L; Zheng D; Li Z; Wu Z
Cell Biol Int; 2018 Sep; 42(9):1250-1258. PubMed ID: 29851220
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney.
Si YN; Bao HG; Xu L; Wang XL; Shen Y; Wang JS; Yang XB
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1843-51. PubMed ID: 25010612
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of connexin 32 attenuates hypoxia/reoxygenation injury in liver cells.
Wang R; Huang F; Chen Z; Li S
J Biochem Mol Toxicol; 2015 Apr; 29(4):189-97. PubMed ID: 25530438
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
20. Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway.
Lin Y; Sheng M; Ding Y; Zhang N; Song Y; Du H; Lu N; Yu W
J Nat Med; 2018 Jun; 72(3):715-723. PubMed ID: 29680964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
